Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Anagenics ( (AU:AN1) ) has shared an update.
Anagenics Limited has applied to the ASX for quotation of 414,682,381 ordinary fully paid shares under its ticker AN1. The securities, issued on 9 February 2026 as part of previously announced transactions, represent a significant listing event that will expand the company’s quoted capital base and potentially enhance liquidity for shareholders.
The application under Appendix 2A formalises the move to have these newly issued securities admitted to trading on the exchange. While the release does not provide additional operational or strategic context, the size of the issuance signals a material adjustment to Anagenics’ capital structure with implications for existing and prospective investors.
More about Anagenics
Anagenics Limited is an Australia-listed company trading under the ASX code AN1. The announcement relates to its ordinary fully paid shares, but no further details on its industry, products, or specific market focus are provided in the release.
Current Market Cap: A$3.42M
For an in-depth examination of AN1 stock, go to TipRanks’ Overview page.